CORT icon

Corcept Therapeutics
CORT

Overview Fund Activity

98 hedge funds and large institutions have $161M invested in Corcept Therapeutics in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 29 reducing their positions, and 6 closing their positions.

Holders
98
Holders Change
+18
Holders Change %
+22.5%
% of All Funds
2.74%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
24
Increased
30
Reduced
29
Closed
6
Calls
$476K
Puts
$25K
Net Calls
+$451K
Net Calls Change
-$2.02M

Top Buyers

1
ISL
1
Ingalls & Snyder LLC
New York
$32.6M
2
Morgan Stanley
2
Morgan Stanley
New York
$8.09M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$1.45M
4
TIM
4
Thornburg Investment Management
New Mexico
$1.26M
5
Millennium Management
5
Millennium Management
New York
$1.19M

Top Sellers

1
Invesco
1
Invesco
Georgia
$0
2
EI
2
EAM Investors
California
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$89K
4
RFC
4
Russell Frank Company
Washington
$424K
5
Deutsche Bank
5
Deutsche Bank
Germany
$383K
Name Holding Trade Value Shares
Change 		Shares
Change %
PTC
101
Petrus Trust Company
Texas
– -$144K -23,901 Closed
VKH
102
Virtu KCG Holdings
New York
– -$77K -12,778 Closed
TRCT
103
Tower Research Capital (TRC)
New York
– -$51K -8,389 Closed
1 2 3 4
5